GSK "GENELEN-ST", Moscow

Accounting reports

Previously








Share:
Name
Garazhno-stroitel'nyy kooperativ "GENELEN-ST"
INN
7734189916
KPP
773401001
OGRN
1037739133343
OKPO
18694173
Address
123458, G.moskva, ul Lykovskaya 2-ya, d. D. 3
Phone
Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
GSK "GENELEN-ST" according to EGRUL

OKVED codeTypeName of activity type
52.21.24Core activity Activities of Parking for vehicles
Registration date
18.01.2003
Registering department
MEZHRAYONNAYA INSPEKTSIYA MNS ROSSII N 39 PO G.MOSKVE

GSK "GENELEN-ST" (Moscow; INN 7734189916) was registered on 18 Jan 2003. Type of ownership of GSK "GENELEN-ST" - Comsumer cooperatives.

Form of ownership of GSK "GENELEN-ST" - Private property.

Principal activities of GSK "GENELEN-ST": activities of parking for vehicles (52.21.24).

Economic indicators

2023

Net profit (RAS) of GSK GENELEN-ST grew over 2023 6.50 times to 26.00 thousand RUB from 4.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 6.25% to 90.00 thousand RUB from 96.00 thousand RUB in 2022.

2022

Net profit (RAS) of GSK GENELEN-ST dropped in 2022 10.75 times to 4.00 thousand RUB from 43.00 thousand RUB over the same period in 2021, the company informed.

Revenue increased in the accounting period by 23.08% to 96.00 thousand RUB from 78.00 thousand RUB over 2021.

2021

Net profit (RAS) of GSK GENELEN-ST grew over 2021 4.30 times to 43.00 thousand RUB from 10.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 7.14% to 78.00 thousand RUB from 84.00 thousand RUB in 2020.

2020

Net profit (RAS) of GSK GENELEN-ST dropped in 2020 2.40 times to 10.00 thousand RUB from 24.00 thousand RUB over the same period in 2019, the company informed.

Revenue decreased in the accounting period by 35.88% to 84.00 thousand RUB from 131.00 thousand RUB in 2019.

2019

Net profit (RAS) of GSK GENELEN-ST grew over 2019 3.43 times to 24.00 thousand RUB from 7.00 thousand RUB over 2018, the company informed.

Revenue decreased in the accounting period by 7.75% to 131.00 thousand RUB from 142.00 thousand RUB in 2018.

2018

Net profit (RAS) of GSK GENELEN-ST grew over 2018 3.50 times to 7.00 thousand RUB from 2.00 thousand RUB over 2017, the company informed.

Revenue decreased in the accounting period by 27.55% to 142.00 thousand RUB from 196.00 thousand RUB in 2017; cost of goods sold decreased by 34.59% to 104.00 thousand RUB from 159.00 thousand RUB; sales profit went up by 2.70% to 38.00 thousand RUB from 37.00 thousand RUB.

2017

Net profit (RAS) of GSK GENELEN-ST dropped in 2017 3.50 times to 2.00 thousand RUB from 7.00 thousand RUB over the same period in 2016, the company informed.

Revenue decreased in the accounting period by 9.26% to 196.00 thousand RUB from 216.00 thousand RUB in 2016; cost of goods sold decreased by 6.47% to 159.00 thousand RUB from 170.00 thousand RUB; sales profit fell by 19.57% to 37.00 thousand RUB from 46.00 thousand RUB.

2016

Net profit (RAS) of GSK GENELEN-ST dropped in 2016 2.29 times to 7.00 thousand RUB from 16.00 thousand RUB over the same period in 2015, the company informed.

Revenue increased in the accounting period by 2.86% to 216.00 thousand RUB from 210.00 thousand RUB over 2015; cost of goods sold grew by 7.59% to 170.00 thousand RUB from 158.00 thousand RUB; sales profit fell by 11.54% to 46.00 thousand RUB from 52.00 thousand RUB.

2014

Net profit (RAS) of GSK GENELEN-ST dropped in 2014 9.67 times to 3.00 thousand RUB from 29.00 thousand RUB over the same period in 2013, the company informed.

Revenue decreased in the accounting period by 28.71% to 221.00 thousand RUB from 310.00 thousand RUB in 2013; cost of goods sold decreased by 23.33% to 184.00 thousand RUB from 240.00 thousand RUB; sales profit fell by 47.14% to 37.00 thousand RUB from 70.00 thousand RUB.

2013

Net profit (RAS) of GSK GENELEN-ST dropped in 2013 4.10 times to 29.00 thousand RUB from 119.00 thousand RUB over the same period in 2012, the company informed.

Revenue decreased in the accounting period by 1.27% to 310.00 thousand RUB from 314.00 thousand RUB in 2012; cost of goods sold grew 1.51 times to 240.00 thousand RUB from 159.00 thousand RUB; sales profit fell 2.21 times to 70.00 thousand RUB from 155.00 thousand RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 327 881
Reports
17 430 633
Rrocessed requests
Extract from EGRUL:
Today, 9:59 PM
Accounting reports:
Today, 9:57 PM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2025
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru